Cellular and Clinical Pharmacology of Fludarabine
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (2) , 93-103
- https://doi.org/10.2165/00003088-200241020-00002
Abstract
In the past decade, fludarabine has had a major impact in increasing the effectiveness of treatment of patients with indolent B-cell malignancies. This has come about in a variety of clinical...Keywords
This publication has 69 references indexed in Scilit:
- Inhibition of the 3′→ 5′ Exonuclease of Human DNA Polymerase ε by Fludarabine-terminated DNAPublished by Elsevier ,1996
- FludarabineDrugs, 1993
- Cellular Pharmacology of Fludarabine Triphosphate in Chronic Lymphocytic Leukemia Cells During Fludarabine TherapyLeukemia & Lymphoma, 1993
- Phase II Clinical Trial of Fludarabine in Chronic Lymphocytic Leukemia on a Weekly Low-Dose ScheduleLeukemia & Lymphoma, 1993
- Metabolism and action of purine nucleoside analogsPharmacology & Therapeutics, 1991
- Eukaryotic DNA ligasesMutation Research/DNA Repair, 1990
- Gene deletion, a mechanism of induced mutation by arabinosyl nucleosidesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- Phase I Clinical Investigation of Fludarabine Phosphate by a Loading-Dose and Continuous-Infusion ScheduleJNCI Journal of the National Cancer Institute, 1988
- Nucleosides of 2-FluoroadenineJournal of Medicinal Chemistry, 1969
- SYNTHESIS OF POTENTIAL ANTICANCER AGENTS. X. 2-FLUOROADENOSINE1Journal of the American Chemical Society, 1957